Tuesday, November 24, 2009 | 6:00 PM - 9:00 PM
Speakers: Gerald M. Edelman (The Neurosciences Institute and The Scripps Research Institute), Paul Ekman (University of California, San Francisco and Paul Ekman Group LLC), and Terrence Deacon (University of California, Berkeley)
S&C celebrates the 150th anniversary of the publication of the landmark book, The Origin of Species, by the most legendary member of NYAS, Charles Darwin. Join Gerald Edelman, Paul Ekman, and Terrence Deacon for an evening of evolution.
Thursday, December 3, 2009 | 6:30 PM - 8:30 PM
Organizers: Jane Hubbard (The Skirball Institute for Biomolecular Medicine), Cathy Savage-Dunn (Queens College, CUNY) and Shai Shaham (The Rockefeller University)
The NY Area C. elegans Discussion Group presents meetings featuring talks by graduate students, post-docs, or laboratory heads from the tri-state area with an emphasis on new and emerging data.
Tuesday, December 15, 2009 | 1:00 PM - 5:00 PM
Speakers: Haim Einat (University of Minnesota), Rif S. El-Mallakh (University of Louisville School of Medicine), Todd Gould (University of Maryland School of Medicine), Alexander B. Niculescu, III (Indiana University School of Medicine)
This symposium will highlight new developments in Bipolar disorder models and biomarker identification, and will reveal how these new strategies can further our understanding of the disease and our ability to identify new therapies.
Monday, January 11, 2010 | 6:30 PM - 8:30 PM
Organizers: Mary Baylies (Sloan Kettering Institute), Laura Johnston (Columbia University), and Jennifer Zallen (Sloan Kettering Institute)
New York Area Drosophila Discussion Group meetings include four presentations by graduate students and post-docs selected from area laboratories by the program committee with an emphasis on new and emerging data.
Tuesday, January 26, 2010 | 9:00 AM - 5:00 PM
Organizers: Lawrence P. Wennogle (Intra-Cellular Therapies, Inc.) and Peter Hutson (Merck and Co., Inc.)
The symposium will focus on phosphodiesterase (PDE) inhibitors for schizophrenia and cognitive disorders and review the theoretical basis of different PDE isoforms as well as the progress towards human clinical testing of these agents.
Monday, November 2, 2009 | 9:00 AM - 5:00 PM
Organizers: Eric Lai (Memorial Sloan-Kettering Cancer Center) and Thomas Tuschl (The Rockefeller University)
This 1-day symposium will explore the role of non-coding RNAs in nervous system development, function and etiology of disease.
Tuesday, October 27, 2009 | 1:00 PM - 5:00 PM
Speakers: Suzanne M. de la Monte (Brown Medical School), William L. Klein (Northwestern University), José A. Luchsinger (Columbia University), Mark Mattson (National Institute on Aging, NIH)
Alzheimer’s disease (AD) has been called Type 3 diabetes, unique to the brain; others suggest that diabetes is a risk factor for AD. This symposium will discuss the significance of cerebral metabolic disturbances in Alzheimer's disease.
Wednesday, September 30, 2009 | 8:30 AM - 7:00 PM
Chair: J. William Langston (The Parkinson's Institute and Clinical Center)
Held in partnership with the Michael J. Fox Foundation, this meeting will highlight novel advances in basic and translational research that impact understanding of Parkinson's Disease and its treatment.
Thursday, September 24, 2009 | 1:00 PM - 3:00 PM
Speaker: Peter S. Jensen, MD (The REACH Institute, Mayo Clinic)
The Lyceum Society is comprised of the Academy's retired and semi-retired members. Talks cover various scientific fields. All Academy members are welcome. All Lyceum meetings (except December) are Brown Bag lunches. Brown Bag: 11:30 am; Lecture & Discussion: 1pm to 3 pm.
|
Annals
Edited by Simon Lovestone (King's College, University of London)
In this Annals volume experts discuss the latest advances in biomarker technologies and biomarker development for brain disorders.
eBriefing
Keynote Speaker: Russell J. Reiter (The University of Texas Health Science Center)
Our bodies use light cues to regulate fundamental cellular processes. A new eBriefing asks, has overexposure to light and shift work in industrialized societies caused cell growth and proliferation to go awry?
Annals
Edited by Simone Dalla Bella (University of Finance and Management, Warsaw, Poland), Nina Kraus (Northwestern University, School of Communication, Evanston, Illinois), Katie Overy (University of Edinburgh - Music, Edinburgh, United Kingdom), Christo Pantev (Institute for Biomagnetism and Biosignalanalysis, Munster University Hospital, Munster, Germany), Joel S. Snyder (Department of Psychology, University of Nevada, Las Vegas, Nevada), Mari Tervaniemi (Cognitive Brain Research Unit, Department of Psychology, University of Helsinki, Finland), Barbara Tillmann (Neurosciences et Systèmes Sensoriels CNRS - Université Claude Bernard, Lyon, France), and Gottfried Schlaug (Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA)
Manuscripts in this Annals volume address how the tools of cognitive neuroscience have provided new insights into music and the brain.
eBriefing
Organizer: Howard Fillit (Alzheimer's Drug Discovery Foundation)
There's no consensus about what cognitive aging is, but mental decline clearly affects most of us as we grow older. This eBriefing explores how cognitive aging relates to other neurodegenerative disorders and how it may be managed.
eBriefing
Speakers: David Riddell (Wyeth Research), Robert Vassar (Northwestern University), Lisa McConlogue (Elan Pharmaceuticals), Ishrut Hussain (GlaxoSmithKline R&D), and Jordan Tang (Oklahoma Medical Research Foundation)
BACE1 is the enzyme that generates the toxic peptide amyloid-β in the brain. Researchers convened at the Academy to discuss efforts to develop a drug that targets BACE1 and prevents amyloid plaque build-up.
Webinar Archive
October 27, 2009
What is the connection between dysregulated neuronal insulin signaling and Alzheimer's disease? In a recent Academy webinar, some researchers argued that the neurodegenerative disease should be considered a type of diabetes.
|